Rathbone Blue Chip Income And Gr I Inc (FUND:B7FN6N7) - Fund price - Overview

Fund Report

Rathbone Blue Chip Income And Growth Institutional Inc

Key Stats
Morningstar® CategoryUK Equity Income
Manager Name-
Inception Date01/03/2012
NAV 23/08/2017GBX 165.90
Day Change0.81%
12 Month Yield3.69%
ISINGB00B7FN6N73
SEDOLB7FN6N7
Dividend FrequencySemi-Annually
Net Assets (mil) 30/06/201787.09 GBP
Wrapper AvailabilityAll
Our Minimum Initial Investment1.00 Share
Pricing FrequencyDaily
Dealing Cut off Time11:00:00
Regular InvestmentYes
Actual Initial Charge0.00%
Exit Charge-
Custody ChargeYes
Fund Ongoing Charge0.86%
AMC0.75%
Fund Rebate0.05%

Morningstar Rating™

StarRatingValueLabel_3

Morningstar Sustainability Rating

Above Average

Above Average


Sustainability Rating as of 30/06/2017

Benchmarks

Fund Benchmark

FTSE AllSh TR GBP

Morningstar® Benchmark

FTSE All Share TR GBP

Growth Of 10,000 (GBP) 31/07/2017

How has this security performed
20132014201520162017
Fund23.445.339.586.337.39
Category25.893.896.338.766.93
Benchmark20.811.180.9816.756.73
  • Fund: Rathbone Blue Chip Income And Growth Institutional Inc
  • Category: UK Equity Income
  • Benchmark: FTSE All Share TR GBP
Trailing Returns % (GBP) 23/08/2017
FundCatBmark
YTD4.986.847.51
3 Years Annualised7.317.767.63
5 Years Annualised10.6011.109.99
10 Years Annualised6.306.666.15

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Investment Objective

The objective of the investment policy is to achieve an above average and steadily increasing income return coupled with capital growth from a portfolio of transferable securities.

Portfolio Profile30/06/2017

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
GlaxoSmithKline PLC Healthcare4.73
IncreaseBunzl PLC Consumer Defensive4.52
IncreaseProvident Financial PLC Financial Services4.52
AstraZeneca PLC Healthcare4.47
Novartis AG Healthcare4.47
Asset Allocation %
LongShortNet
Stocks92.900.0092.90
Bonds0.000.000.00
Cash11.023.927.10
Other0.000.000.00
Top Stock Regions
Region%
United Kingdom86.95
Europe - ex Euro7.12
Eurozone5.93
United States0.00
Canada0.00
Top Stock Sectors
Stock Sector%
Consumer Defensive25.57
Financial Services21.96
Healthcare14.72
Consumer Cyclical12.49
Real Estate8.46
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.